Back to search

Article

Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL

2025-12-18

Abstract excerpt

Pediatric B-cell acute lymphoblastic leukemia (B-ALL) is effectively controlled with contemporary multi-agent chemotherapy, resulting to 5-year survival rates above 90%. However, relapse occurs in 15-20% of patients due to minimal residual disease (MRD), characterized by the presence of persisting and resistant leukemic cells, and associated with a poor clinical outcome. Despite its prognostic relevance, the molec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6c4204de-c163-5443-9711-1e68caaa37a0
DOI
10.64898/2025.12.16.694550
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALLDOI 10.64898/2025.12.16.694550
Select a neighboring publication to make it the new centre.